AARTI DRUGS
Sector : Pharmaceuticals and health care | Aarti Group | Smallcap | BSE
Here's the live share price of Aarti Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.46₹ 12.05
As on Nov 3, 2025, 4:01 PM IST
Aarti Drugs Price Performance
Today's LowToday's High
₹488.85₹505.30
₹502.70
52 Weeks' Low52 Weeks' High
₹312.50₹574.95
₹502.70
Open Price
₹491.00
Prev. Close
₹490.65
Volume
9,927
Over the last 5 years, the share price of Aarti Drugs has declined 5.16% CAGR. Over the past year, the corresponding return has been 3.10%.
Aarti Drugs’s current P/E of 24.30x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Aarti Drugs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aarti Drugs | 1.75 | 2.91 | 2.72 | 44.00 | 3.10 | 1.95 | -5.16 |
| Sun Pharmaceutical Industries | 0.21 | 4.09 | 4.55 | -6.87 | -8.37 | 18.13 | 29.41 |
| Divi's Laboratories | 3.01 | 18.83 | 6.72 | 11.24 | 15.00 | 20.95 | 17.36 |
| Torrent Pharmaceuticals | 1.13 | 1.56 | -1.51 | 11.14 | 12.82 | 28.97 | 23.26 |
| Cipla | -4.56 | -0.15 | 0.69 | -0.92 | -3.05 | 8.78 | 15.02 |
| Dr. Reddy's Laboratories | -6.82 | -4.00 | -1.90 | 1.15 | -4.93 | 9.63 | 4.26 |
| Mankind Pharma | -1.10 | -1.38 | -6.14 | 0.97 | -10.61 | 19.09 | 11.05 |
| Zydus Lifesciences | -2.48 | -1.11 | 3.35 | 10.76 | -2.32 | 31.30 | 19.05 |
| Lupin | 2.82 | 0.21 | 6.45 | -3.50 | -9.66 | 41.03 | 16.84 |
| Alkem Laboratories | 1.43 | 3.02 | 14.92 | 10.89 | -3.15 | 20.35 | 16.18 |
| Aurobindo Pharma | 6.46 | 6.27 | 7.00 | -4.69 | -17.55 | 28.09 | 8.74 |
| Abbott India | -2.87 | -2.64 | -13.64 | -5.43 | -0.77 | 13.95 | 13.40 |
| Glenmark Pharmaceuticals | 4.15 | -3.30 | -8.37 | 37.68 | 12.01 | 66.11 | 31.97 |
| Laurus Labs | 5.39 | 11.82 | 14.99 | 57.19 | 95.23 | 27.49 | 26.52 |
| Biocon | 5.25 | 9.09 | -1.29 | 18.63 | 18.91 | 11.88 | -1.32 |
| GlaxoSmithKline Pharmaceuticals | -2.38 | -0.36 | -8.49 | -5.88 | -1.64 | 24.87 | 13.76 |
| Anthem Biosciences | -2.34 | -8.90 | -4.74 | -3.74 | -3.74 | -1.26 | -0.76 |
| Ipca Laboratories | 3.31 | -1.35 | -9.79 | -4.97 | -18.56 | 12.27 | 2.64 |
| Gland Pharma | 1.53 | -0.57 | -0.50 | 40.19 | 19.72 | 3.29 | 1.58 |
| Ajanta Pharma | 5.14 | 5.79 | -5.82 | -1.81 | -17.59 | 24.26 | 19.30 |
Over the last one year, Aarti Drugs has gained 3.10% compared to peers like Sun Pharmaceutical Industries (-8.37%), Divi's Laboratories (15.00%), Torrent Pharmaceuticals (12.82%). From a 5 year perspective, Aarti Drugs has underperformed peers relative to Sun Pharmaceutical Industries (29.41%) and Divi's Laboratories (17.36%).
Aarti Drugs Financials
Aarti Drugs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 491.96 | 494.98 |
| 10 | 501.01 | 498.35 |
| 20 | 504.2 | 500.87 |
| 50 | 496.82 | 498.31 |
| 100 | 492.11 | 486.12 |
| 200 | 443.22 | 472.03 |
Aarti Drugs Share Holding Pattern
In the latest quarter, Aarti Drugs saw a drop in promoter holding to 54.73%, while DII stake decreased to 9.90%, FII holding rose to 2.68%, and public shareholding moved up to 32.70% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Aarti Drugs Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 63,87,722 | 1.88 | 310.76 | |
| 15,20,893 | 1.19 | 73.99 |
* Excluding Index & Arbitrage Funds
Aarti Drugs Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 01, 2025, 2:07 AM IST | Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Nov 01, 2025, 1:56 AM IST | Aarti Drugs Ltd - Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30, 20 |
| Oct 10, 2025, 12:34 AM IST | Aarti Drugs Ltd - Crisil ESG Rating |
| Oct 09, 2025, 12:04 AM IST | Aarti Drugs Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Sep 25, 2025, 2:28 AM IST | Aarti Drugs Ltd - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
About Aarti Drugs
Aarti Drugs Ltd. is a Public Limited Listed company incorporated on 28/09/1984 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L37060MH1984PLC055433 and registration number is 055433. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company's Total Operating Revenue is Rs. 2173.65 Cr. and Equity Capital is Rs. 91.27 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. 198, M.I.D.C., Palghar District Maharashtra 401506
- Contact
Management
- Mr. Chandrakant V GogriChairman Emeritus
- Mr. Prakash M PatilChairman & M.D & CEO
- Mr. Rashesh C GogriManaging Director
- Mr. Harshit M SavlaJoint Managing Director
- Mr. Harit P ShahExecutive Director
- Mr. Uday M PatilExecutive Director
- Mr. Narendra J SalviNon Executive Director
- Mr. Ankit V PalejaIndependent Director
- Prof. Bhaskar N ThoratIndependent Director
- Mrs. Neha R GadaIndependent Director
- Mr. Hasmukh B DedhiaIndependent Director
- Mr. Sandeep M JoshiIndependent Director
- Mr. Ajit E VenugopalanIndependent Director
FAQs on Aarti Drugs Share Price
What is the share price of Aarti Drugs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aarti Drugs is ₹502.70 as on Nov 03, 2025.
What kind of stock is Aarti Drugs?
The Aarti Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Aarti Drugs?
The market cap of Aarti Drugs is ₹4,588.14 Cr as on Nov 03, 2025.
What are today's High and Low prices of Aarti Drugs?
Today’s highest and lowest price of Aarti Drugs are ₹505.30 and ₹488.85.
What are the 52 Week High and 52 Week Low of Aarti Drugs?
The 52-week high/low is the highest and lowest price at which Aarti Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Aarti Drugs is ₹574.95 and 52-week low of Aarti Drugs is ₹312.50 as on Nov 03, 2025.
How has the Aarti Drugs performed historically in terms of returns?
The Aarti Drugs has shown returns of 2.46% over the past day, 2.91% for the past month, 2.72% over 3 months, 3.1% over 1 year, 1.95% across 3 years, and -5.16% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Aarti Drugs?
P/E ratio of and PB ratio of Aarti Drugs are 24.30 and 3.59 on Nov 03, 2025. While the company gives a dividend yield of 0.20 per annum.
✕
Market Pulse